Italy, Norway and Denmark temporarily suspend vaccination with Astrazeneca dose due to cases of thrombosis in vacancies | International | Notice

Estonia, Lithuania, Latvia and Luxembourg will also suspend immunization with the same dose as the other European countries.

These Norwegian and Italian authorities have announced that they will suspend the use of the AstraZeneca vehicle against the COVID-19, despite the fact that Denmark has the right to register serious cases of tornadoes in persons whom it has received.

The General Board of Health of Denmark has communicated before the suspension for 14 days of the vaccine applying a “precautionary” principle, although it has also produced a death, although it has not been able to demonstrate a direct relationship.

“We hope to see if there is any connection between the vaccine and these cases of thrombi”, said Geir Bukholm, Director of Infections at the Institute of Public Health (FHI) in Norway.

Norway, which is part of the European Economic Area for the European Union, has not registered cases of thrombosis in persons receiving this medicine, but has decided to paralyze its use of the European Medicines Agency (EMA) study on information on problems with coagulation diagnosed in various countries.

The Italian Medicines Agency (AIFA) also informs these juveniles that it has temporarily suspended the vaccination with a lot of AstraZeneca pharmaceuticals for precaution, while informing about the problems of coagulation diagnosed in various European countries.

Withdrawal of AstraZeneca vacant lot after the death of a person immunized against COVID-19

The agency explained in a statement that despite the information about health problems detected in other European countries, it has blocked the cancellation of the dose ABV2856.

In addition, the right is reserved to take new media, when necessary, also in coordination with the EMA.

The AIFA states that at present “no causal angle has been established between the administration of the vaccine and these events” detected in other countries and that the necessary controls are being carried out, revealing the relevant clinical documentation.

The samples of this lot will be analyzed by the Instituto Nacional de Salud italiano.

In parallel, the Fiscalía de Syracuse (Sicily, sur) has launched an investigation into the deaths of a 43-year-old soldier, who suffered a cardiac injury in the last hours, had a relationship with the AstraZeneca vaccine recently , según EFE.

The Fiscalía de Catania (Sicilia, sur) has also opened another expedition, currently unsuspecting, over the death of another 50-year-old police officer, who had 12 days before receiving the vaccine from the pharmaceutical company.

The EMA has assured these juveniles in the Netherlands that it is currently studying information on coagulation problems diagnosed in various European countries in conjunction with the reception of an AstraZeneca vaccine and that it may issue a “high resolution” to our council pharmacy in the European Union (EU).

German experts do not recommend AstraZeneca’s vacancy for mayors for 65 years

The European regulator has assured the markets in a preliminary analysis that does not create a specific problem with an AstraZeneca lot withdrawn from Austria as a means of precaution, the death of a person diagnosed with multiple thrombosis and multiple evacuation.

Estonia, Lithuania, Latvia and Luxembourg have also suspended the immunization with the dose of this lot in concrete terms, which were received by 17 countries of the European Union, including Spain, Poland, Malta, France and Greece, according to the EMA.

In contrast to its vehicles in Norway and Denmark, Sweden has returned to its temporary restraining order on the use of this vehicle.

“We believe that we do not have a sufficient base to suspend the evacuation with AstraZeneca”, he said in the press conference of the sanitary authorities Veronica Arthurson, of the Swedish Medicines Agency (I)

Source